These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 26936761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leishmaniasis: an update of current pharmacotherapy.
    Sundar S, Chakravarty J.
    Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of visceral leishmaniasis in children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [Abstract] [Full Text] [Related]

  • 4. [Visceral leishmaniasis: new drugs].
    Minodier P, Robert S, Retornaz K, Garnier JM.
    Arch Pediatr; 2003 Dec; 10 Suppl 5():550s-556s. PubMed ID: 15022780
    [Abstract] [Full Text] [Related]

  • 5. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
    Patole S, Burza S, Varghese GM.
    Int J Infect Dis; 2014 Aug; 25():204-6. PubMed ID: 24927662
    [Abstract] [Full Text] [Related]

  • 6. Visceral Leishmaniasis and HIV coinfection in East Africa.
    Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J.
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2869. PubMed ID: 24968313
    [Abstract] [Full Text] [Related]

  • 7. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I, Cappel MA, Keeling JH.
    Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
    [Abstract] [Full Text] [Related]

  • 8. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Jul; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 9. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
    Kumar D, Ramesh V, Verma S, Ramam M, Salotra P.
    Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
    [No Abstract] [Full Text] [Related]

  • 10. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, Kadivar MR.
    Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
    [Abstract] [Full Text] [Related]

  • 11. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF, Morquin D, Reynes J, Chirouze C, Hoen B, Le Moing V.
    Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
    [Abstract] [Full Text] [Related]

  • 12. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN, Croft SL.
    Trans R Soc Trop Med Hyg; 1993 Oct; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract] [Full Text] [Related]

  • 13. The nexus between Leishmania & HIV: Debilitating host immunity and Hastening Comorbid disease burden.
    Dhulipalla M, Chouhan G.
    Exp Parasitol; 2024 Oct; 265():108826. PubMed ID: 39147120
    [Abstract] [Full Text] [Related]

  • 14. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
    Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, Mitra G, Kumar D, Pandey K, Van Geertruyden JP, Boelaert M, Burza S.
    Clin Infect Dis; 2015 Oct 15; 61(8):1255-62. PubMed ID: 26129756
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D, Kulshrestha A, Singh R, Salotra P.
    Antimicrob Agents Chemother; 2009 Feb 15; 53(2):835-8. PubMed ID: 19015344
    [Abstract] [Full Text] [Related]

  • 16. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 15; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
    Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, den Boer M, Davidson RN.
    Clin Infect Dis; 2006 Aug 01; 43(3):357-64. PubMed ID: 16804852
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of leishmaniasis in India.
    Thakur CP.
    Indian J Pediatr; 1987 Aug 01; 54(1):7-10. PubMed ID: 3030933
    [No Abstract] [Full Text] [Related]

  • 19. Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV.
    Adriaensen W, Cuypers B, Cordero CF, Mengasha B, Blesson S, Cnops L, Kaye PM, Alves F, Diro E, van Griensven J.
    EBioMedicine; 2020 May 01; 55():102748. PubMed ID: 32361248
    [Abstract] [Full Text] [Related]

  • 20. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
    Minodier P, Retornaz K, Horelt A, Garnier JM.
    Fundam Clin Pharmacol; 2003 Apr 01; 17(2):183-8. PubMed ID: 12667228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.